SPBC21C3.06 Antibody

What is SPBC21C3.06 protein and its antibody?

SPBC21C3.06 is a protein found in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. The SPBC21C3.06 antibody (product code CSB-PA873792XA01SXV, UniProt accession number Q9P7L7) is a research tool designed to detect and quantify this specific protein in various experimental applications . This antibody is typically generated by immunizing host animals with antigenic determinants from the SPBC21C3.06 protein, resulting in polyclonal or monoclonal antibodies that specifically recognize epitopes on this target protein.

What applications is the SPBC21C3.06 antibody validated for?

Similar to other S. pombe antibodies, SPBC21C3.06 antibody is commonly validated for applications including Western blotting (WB), enzyme-linked immunosorbent assay (ELISA), and potentially immunohistochemistry (IHC) . The specific validation parameters depend on the manufacturer and antibody production methods. When selecting this antibody, researchers should verify which applications have been experimentally validated by the supplier rather than assuming cross-application functionality.

How does SPBC21C3.06 antibody compare to other S. pombe protein antibodies?

Antibodies targeting various S. pombe proteins, such as SPBC21C3.04c and SPBC21C3.15c, are available for research purposes . Each antibody has distinct specificity profiles and validated applications. The SPBC21C3.04c antibody, for example, targets a probable 54S ribosomal protein L34 (mitochondrial), while SPBC21C3.06 antibody targets a different protein within the same organism . Researchers should evaluate comparative specificity when multiple cellular components need to be studied simultaneously.

What is the optimal protocol for Western blotting with SPBC21C3.06 antibody?

For Western blotting with SPBC21C3.06 antibody, researchers should optimize several parameters to achieve reliable results. Begin with protein extraction from S. pombe using appropriate lysis buffers that preserve protein structure. Determine the optimal antibody concentration by testing a dilution series (typically 1:500 to 1:5000) to identify the concentration that provides the best signal-to-noise ratio . Use both positive and negative controls to validate results, including wild-type S. pombe extracts and, ideally, extracts from strains with SPBC21C3.06 deletions or known expression variations. The protein transfer efficiency should be verified using reversible staining methods before immunodetection.

How should I validate SPBC21C3.06 antibody specificity for my research?

Validating antibody specificity is critical for reliable results. A comprehensive validation approach for SPBC21C3.06 antibody should include:

• Genetic validation: Test the antibody in SPBC21C3.06 knockout or knockdown S. pombe strains where the target should be absent or reduced .

• Expression validation: Use recombinant SPBC21C3.06 protein as a positive control.

• Cross-reactivity testing: Evaluate potential cross-reactivity with related S. pombe proteins.

• Orthogonal detection methods: Confirm results using independent techniques like mass spectrometry .

• Reproducibility testing: Ensure consistent results across multiple experimental replicates.

This multi-pronged approach helps ensure that signals detected truly represent the SPBC21C3.06 protein rather than non-specific binding to other cellular components.

What controls are essential when using SPBC21C3.06 antibody?

For rigorous experimental design with SPBC21C3.06 antibody, implement the following controls:

These controls help distinguish specific signals from experimental artifacts and enable meaningful interpretation of results .

How can I use SPBC21C3.06 antibody in multiplex immunofluorescence studies?

For multiplex immunofluorescence with SPBC21C3.06 antibody, consider these methodological approaches:

• Antibody compatibility: Ensure that SPBC21C3.06 antibody is compatible with other primary antibodies by selecting those raised in different host species.

• Sequential staining: If antibodies are from the same host, employ sequential staining with blocking steps between applications.

• Signal amplification: For low-abundance proteins, use tyramide signal amplification or quantum dots to enhance detection sensitivity.

• Spectral unmixing: Employ spectral imaging and computational unmixing to resolve overlapping fluorophore emissions.

• Optimized fixation: Different fixation methods may preserve distinct epitopes; test paraformaldehyde, methanol, and hybrid fixation protocols .

This approach allows simultaneous visualization of SPBC21C3.06 protein in relation to other cellular components, providing spatial context for protein function studies.

What strategies can resolve contradictory results with SPBC21C3.06 antibody?

When facing contradictory results using SPBC21C3.06 antibody, systematically investigate potential sources of variability:

• Antibody lot variation: Different production lots may have varying specificities; compare results across lots.

• Epitope accessibility: Test multiple antigen retrieval methods that might expose different protein conformations.

• Sample preparation effects: Compare different lysis buffers and protein extraction protocols.

• Cross-platform validation: Verify results using independent techniques (e.g., mass spectrometry, RNA-seq).

• Cell cycle effects: S. pombe protein expression may vary throughout the cell cycle; synchronize cultures or analyze cell cycle-sorted populations .

Documenting all experimental conditions meticulously allows identification of variables contributing to result discrepancies.

How do post-translational modifications affect SPBC21C3.06 antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody-epitope interactions. For SPBC21C3.06 antibody:

• Modification-sensitive epitopes: Determine if the antibody recognizes epitopes potentially subject to phosphorylation, acetylation, or other modifications.

• Parallel detection approaches: Use modification-specific antibodies alongside total SPBC21C3.06 antibody.

• Enzymatic treatment: Pre-treat samples with phosphatases or deacetylases to remove specific modifications.

• Mass spectrometry validation: Confirm the presence of specific PTMs using proteomic approaches.

• Mutational analysis: Express SPBC21C3.06 with mutation at modification sites to assess antibody binding dependency .

Understanding the impact of PTMs helps interpret experimental variability and can provide insights into regulatory mechanisms affecting the target protein.

How can I improve SPBC21C3.06 antibody sensitivity in low-expression contexts?

Detecting low-abundance SPBC21C3.06 protein requires sensitivity optimization strategies:

• Sample enrichment: Use subcellular fractionation to concentrate the compartment containing SPBC21C3.06.

• Signal amplification: Employ tyramide signal amplification or poly-HRP detection systems.

• Increased sample loading: Load more total protein while ensuring linear detection range.

• Extended exposure: Optimize exposure times while monitoring background signals.

• Enhanced chemiluminescence: Use high-sensitivity ECL substrates for Western blotting.

• Optimized blocking: Test different blocking agents (BSA, milk, commercial blockers) to reduce background while preserving specific signals .

These approaches can significantly improve detection of low-abundance proteins while maintaining specificity.

What are the common pitfalls when quantifying SPBC21C3.06 expression levels?

Accurate quantification of SPBC21C3.06 protein faces several methodological challenges:

• Non-linear detection range: Ensure measurements fall within the linear dynamic range of detection systems.

• Inconsistent loading: Use total protein normalization methods rather than single housekeeping proteins.

• Antibody saturation: Excessive primary or secondary antibody can saturate signals, obscuring true differences.

• Image acquisition limitations: Avoid pixel saturation during digital image capture.

• Batch effects: Process all comparative samples simultaneously to minimize inter-assay variation.

• Software quantification biases: Validate quantification using multiple analysis methods and software packages .

Addressing these issues helps ensure that measured differences in protein levels accurately reflect biological reality rather than technical artifacts.

How should SPBC21C3.06 antibody storage conditions be optimized for long-term studies?

Maintaining antibody performance over time requires careful storage optimization:

Proper storage maximizes antibody shelf-life and ensures consistent performance across longitudinal studies .

What statistical approaches are most appropriate for analyzing SPBC21C3.06 expression data?

Statistical analysis of SPBC21C3.06 expression data should account for experimental design and data characteristics:

• Normality testing: Determine if data follows normal distribution using Shapiro-Wilk or Kolmogorov-Smirnov tests.

• Parametric vs. non-parametric: Use t-tests or ANOVA for normally distributed data; Mann-Whitney or Kruskal-Wallis for non-normal data.

• Multiple testing correction: Apply Bonferroni or Benjamini-Hochberg corrections when performing multiple comparisons.

• Effect size reporting: Include Cohen's d or similar metrics to quantify magnitude of differences.

• Power analysis: Calculate required sample sizes to detect biologically meaningful differences.

• Reproducibility metrics: Report intra- and inter-assay coefficients of variation.

These approaches ensure statistical rigor and support reproducibility of findings in S. pombe protein expression studies.

What information must be included when publishing research using SPBC21C3.06 antibody?

For rigorous reporting of SPBC21C3.06 antibody-based research, include:

• Antibody identifiers: Catalog number, lot number, RRID (Research Resource Identifier).

• Validation evidence: Document specificity tests performed and their results.

• Experimental conditions: Detailed protocols including blocking agents, antibody dilutions, incubation times and temperatures.

• Image acquisition parameters: Exposure settings, gain, offset, and digital processing details.

• Quantification methods: Software used, region of interest definition, background subtraction approach.

• Raw data availability: Provide access to unprocessed images and numerical data .

Complete methodological transparency enables proper evaluation and reproducibility of published findings.

How can SPBC21C3.06 antibody data be integrated with other -omics datasets?

Integrating antibody-based protein data with other -omics approaches provides comprehensive insights:

• Correlation analysis: Compare protein levels with corresponding mRNA abundance from RNA-seq.

• Pathway enrichment: Map protein expression changes to known cellular pathways using tools like GO enrichment.

• Network analysis: Position SPBC21C3.06 within protein interaction networks using STRING or similar databases.

• Multi-omics visualization: Use tools like Cytoscape or R packages to create integrated visualizations.

• Causal modeling: Apply Bayesian approaches to infer causal relationships between different molecular levels.

• Machine learning integration: Employ supervised learning to identify patterns across multiple data types .

This integrated approach places antibody-based protein quantification within broader biological contexts, enhancing mechanistic understanding of S. pombe cellular processes.

What are the emerging applications for SPBC21C3.06 antibody in S. pombe research?

As S. pombe research continues to evolve, SPBC21C3.06 antibody applications are expanding to include emerging methodologies such as super-resolution microscopy, proximity labeling approaches, and microfluidic-based single-cell protein analysis . These advanced techniques require rigorous validation but offer unprecedented insights into protein localization, interaction networks, and heterogeneity within cell populations. Researchers should continuously evaluate new applications while maintaining fundamental validation principles to ensure data reliability.

How might advances in antibody technology impact future SPBC21C3.06 research?

Future antibody technologies will likely enhance SPBC21C3.06 research through developments in recombinant antibody production, nanobody engineering, and multiplexed detection systems . Advances in proteome-wide specificity testing will improve validation standards and enable more confident interpretation of results . Additionally, integration with CRISPR-based genome editing in S. pombe will facilitate more sophisticated functional studies combining genetic manipulation with improved protein detection methodologies.